Project

BREVAS: A Phase 3, multi-center, multinational, randomized, double-blind Study to evaluate the efficacy and safety of Belimumab (HGS1006) in combination with Azathioprine for the maintenance of remission in Wegener’s Granulomatosis and Microscopic Polyangiitis

Completed · 2013 until 2017

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2013
End Date
2017
Financing
Industry
Keywords
Morbus Wegener, Belimumab, Granulomatose
Brief description/objective

Belimumab bei Patienten mit Wegener Granulomatose nach Induktion mit Rituximab und Prednison